Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
<p>SEATTLE and RICHMOND, BC, Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. (SZSE: 301047), today announced a non-exclusive licensing agreement covering Monod Bio's...</p>
Read original article ↗
Related Articles
Taming Hybrid Cloud Chaos: Secure and Efficient Kubernetes Across Clouds
Extending containerized applications to hybrid cloud and edge infrastructure often doubles operational overhead before d